title: Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis--a randomized study.
authors.forename: Visnja
authors.initials: V
authors.lastname: Skerk
authors.forename: I
authors.initials: I
authors.lastname: Krhen
authors.forename: M
authors.initials: M
authors.lastname: Lisić
authors.forename: J
authors.initials: J
authors.lastname: Begovac
authors.forename: V
authors.initials: V
authors.lastname: Cajić
authors.forename: S
authors.initials: S
authors.lastname: Zekan
authors.forename: Vedrana
authors.initials: V
authors.lastname: Skerk
authors.forename: S L
authors.initials: SL
authors.lastname: Sternak
authors.forename: A
authors.initials: A
authors.lastname: Topić
authors.forename: S
authors.initials: S
authors.lastname: Schönwald
mesh_terms: D000328:Adult; D000368:Aged; D017963:Azithromycin / Q000008:administration & dosage*; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy*; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011472:Prostatitis / Q000188:drug therapy* / Q000382:microbiology*; D016896:Treatment Outcome
chemical_list: D017963:Azithromycin